STEVENSON, Md., Nov. 27, 2016 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of purchasers of Avid Technology, Inc. (Nasdaq:AVID) (“Avid” or the “Company”) common stock during the period between August 4, 2016 and November 9, 2016, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 20, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Avid common stock during the Class Period. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that because the Company had not launched all the enterprise level features for its new NEXIS solution product offerings, its enterprise customers were deferring renewals and purchases.
According to the complaint, following a November 9, 2016 disclosure that both its bookings and revenues had come in considerably lower than the Company had led the investment community to expect, that some existing enterprise clients deferred normal upgrade and renewal decisions, and new customers postponed investments until the release of functionality targeted to the enterprise market, the value of Avid shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Avid common stock purchased on or after August 4, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 



